Intravitreal bevacizumab for chronic central serous chorioretinopathy;Intravitreales Bevacizumab bei chronischer Retinopathia centralis serosa

Ophthalmologe

Volumn 105, Issue 10, 2008, Pages 943-945

  Niegel, M F ^a   Schrage, N F ^a   Christmann, S ^a   Degenring, R F ^a  

^a KLINIKEN DER STADT KÖLN GGMBH   (Germany)

Author keywords

Anti VEGF; Avastin; Bevacizumab; Central serous chorioretinopathy; Intravitreal injection

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY;

ARTICLE; CASE REPORT; CHORIORETINITIS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INJECTION; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; VITREOUS BODY;

ANTIBODIES, MONOCLONAL; CHORIORETINITIS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MIDDLE AGED; TOMOGRAPHY, OPTICAL COHERENCE; VITREOUS BODY;

EID: 63349090065     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-008-1691-5     Document Type: Article

References (10)

1. Chan WM, Lai TY, Liu DT, Lam DS (2007) Intravitreal Bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctuate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143: 977-983.
2. Gonzales C (1992) Serous retinal detachment. Value of acetazolamide. J Fr Ophthalmol 15: 529-536.
3. Haimovici R, Koh S, Gagnon DR et al. Central Serous Chorioretinopathy Case Control Study Group (2004) Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 111: 244-249.
4. Holz FG (2000) Akute und chronische idiopathische Chorioretinopathia centralis serosa. In: Kampik A, Grehn F (Hrsg) Augenärztliche Differentialdiagnose. Thieme, Stuttgart.
5. Jonas JB, Kamppeter BA (2005) Intravitreal triamcinolone acetonide and central serous chorioretinopathy. Br J Ophthalmol 89: 386-387.
6. Klatt C, Elsner H, Pörksen E et al. (2006) Selektive Retina-Therapie bei Retinopathia centralis serosa mit Pigmentepithelabhebung. Ophthalmologe 103: 850-855.
7. Koh AHC (2006) Photodynamic therapy for focal RPE leaks. Ophthalmology 11: 2110. e1-2110. e3.
8. Mennel S, Barbazetto I, Meyer CH et al. (2007) Ocular photodynamic therapy standard applications and new indications (part 2). Review of the literature and personal experience. Ophthalmologica 221: 282-291.
9. Otsuka S, Ohba N, Nakao K (2002) A long-term follow-up study of severe variant of central serous chorioretinopathy. Retina 22: 25-32.
10. Tittl MK, Spaide RF, Wong D et al. (1999) Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 128: 63-68.